Copyright Reports & Markets. All rights reserved.

Global Nicotine Gums and Lozenges Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicotine Gums and Lozenges Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 2 mg/piece
    • 1.3.3 4 mg/piece
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicotine Gums and Lozenges Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Withdrawal Clinics
    • 1.4.3 Medical Practice
    • 1.4.4 Individual Smokers
    • 1.4.5 Others
  • 1.5 Global Nicotine Gums and Lozenges Market Size & Forecast
    • 1.5.1 Global Nicotine Gums and Lozenges Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Nicotine Gums and Lozenges Sales Quantity (2020-2031)
    • 1.5.3 Global Nicotine Gums and Lozenges Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Nicotine Gums and Lozenges Product and Services
    • 2.1.4 Novartis Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Perrigo Company
    • 2.2.1 Perrigo Company Details
    • 2.2.2 Perrigo Company Major Business
    • 2.2.3 Perrigo Company Nicotine Gums and Lozenges Product and Services
    • 2.2.4 Perrigo Company Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Perrigo Company Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Nicotine Gums and Lozenges Product and Services
    • 2.3.4 Pfizer Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Fertin Pharma
    • 2.4.1 Fertin Pharma Details
    • 2.4.2 Fertin Pharma Major Business
    • 2.4.3 Fertin Pharma Nicotine Gums and Lozenges Product and Services
    • 2.4.4 Fertin Pharma Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Fertin Pharma Recent Developments/Updates
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Nicotine Gums and Lozenges Product and Services
    • 2.5.4 Johnson & Johnson Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Johnson & Johnson Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Nicotine Gums and Lozenges Product and Services
    • 2.6.4 Cipla Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Alkalon
    • 2.7.1 Alkalon Details
    • 2.7.2 Alkalon Major Business
    • 2.7.3 Alkalon Nicotine Gums and Lozenges Product and Services
    • 2.7.4 Alkalon Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Alkalon Recent Developments/Updates
  • 2.8 GSK
    • 2.8.1 GSK Details
    • 2.8.2 GSK Major Business
    • 2.8.3 GSK Nicotine Gums and Lozenges Product and Services
    • 2.8.4 GSK Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 GSK Recent Developments/Updates
  • 2.9 Reynolds American
    • 2.9.1 Reynolds American Details
    • 2.9.2 Reynolds American Major Business
    • 2.9.3 Reynolds American Nicotine Gums and Lozenges Product and Services
    • 2.9.4 Reynolds American Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Reynolds American Recent Developments/Updates
  • 2.10 Dr. Reddy's Laboratories
    • 2.10.1 Dr. Reddy's Laboratories Details
    • 2.10.2 Dr. Reddy's Laboratories Major Business
    • 2.10.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product and Services
    • 2.10.4 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Dr. Reddy's Laboratories Recent Developments/Updates

3 Competitive Environment: Nicotine Gums and Lozenges by Manufacturer

  • 3.1 Global Nicotine Gums and Lozenges Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Nicotine Gums and Lozenges Revenue by Manufacturer (2020-2025)
  • 3.3 Global Nicotine Gums and Lozenges Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Nicotine Gums and Lozenges by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Nicotine Gums and Lozenges Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Nicotine Gums and Lozenges Manufacturer Market Share in 2024
  • 3.5 Nicotine Gums and Lozenges Market: Overall Company Footprint Analysis
    • 3.5.1 Nicotine Gums and Lozenges Market: Region Footprint
    • 3.5.2 Nicotine Gums and Lozenges Market: Company Product Type Footprint
    • 3.5.3 Nicotine Gums and Lozenges Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicotine Gums and Lozenges Market Size by Region
    • 4.1.1 Global Nicotine Gums and Lozenges Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Nicotine Gums and Lozenges Consumption Value by Region (2020-2031)
    • 4.1.3 Global Nicotine Gums and Lozenges Average Price by Region (2020-2031)
  • 4.2 North America Nicotine Gums and Lozenges Consumption Value (2020-2031)
  • 4.3 Europe Nicotine Gums and Lozenges Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Nicotine Gums and Lozenges Consumption Value (2020-2031)
  • 4.5 South America Nicotine Gums and Lozenges Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Nicotine Gums and Lozenges Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 5.2 Global Nicotine Gums and Lozenges Consumption Value by Type (2020-2031)
  • 5.3 Global Nicotine Gums and Lozenges Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 6.2 Global Nicotine Gums and Lozenges Consumption Value by Application (2020-2031)
  • 6.3 Global Nicotine Gums and Lozenges Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 7.2 North America Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 7.3 North America Nicotine Gums and Lozenges Market Size by Country
    • 7.3.1 North America Nicotine Gums and Lozenges Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Nicotine Gums and Lozenges Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 8.2 Europe Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 8.3 Europe Nicotine Gums and Lozenges Market Size by Country
    • 8.3.1 Europe Nicotine Gums and Lozenges Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Nicotine Gums and Lozenges Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Nicotine Gums and Lozenges Market Size by Region
    • 9.3.1 Asia-Pacific Nicotine Gums and Lozenges Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Nicotine Gums and Lozenges Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 10.2 South America Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 10.3 South America Nicotine Gums and Lozenges Market Size by Country
    • 10.3.1 South America Nicotine Gums and Lozenges Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Nicotine Gums and Lozenges Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicotine Gums and Lozenges Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Nicotine Gums and Lozenges Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Nicotine Gums and Lozenges Market Size by Country
    • 11.3.1 Middle East & Africa Nicotine Gums and Lozenges Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Nicotine Gums and Lozenges Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Nicotine Gums and Lozenges Market Drivers
  • 12.2 Nicotine Gums and Lozenges Market Restraints
  • 12.3 Nicotine Gums and Lozenges Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicotine Gums and Lozenges and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicotine Gums and Lozenges
  • 13.3 Nicotine Gums and Lozenges Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicotine Gums and Lozenges Typical Distributors
  • 14.3 Nicotine Gums and Lozenges Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nicotine Gums and Lozenges market size was valued at US$ 905 million in 2024 and is forecast to a readjusted size of USD 1354 million by 2031 with a CAGR of 6.2% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Nicotine gums and lozenges are over-the-counter nicotine replacement therapy (NRT) products designed to help individuals quit smoking by reducing withdrawal symptoms and nicotine cravings. These products deliver controlled doses of nicotine to the bloodstream through oral absorption, offering a safer alternative to smoking by avoiding harmful tobacco-related toxins. Nicotine gums are chewed to release nicotine gradually, while lozenges dissolve in the mouth, providing a discreet and convenient option for smokers seeking to manage their addiction. Both forms are widely recommended as part of smoking cessation programs and have been shown to significantly increase the chances of quitting successfully when used correctly.
    The market for nicotine gums and lozenges is driven by the increasing global awareness of the health risks associated with smoking and the growing demand for effective smoking cessation aids. Government initiatives, public health campaigns, and stricter regulations on tobacco products have encouraged more individuals to quit smoking, fueling the adoption of nicotine replacement therapies. Additionally, rising healthcare costs and the shift toward preventive healthcare further support market growth. The convenience, accessibility, and non-invasive nature of gums and lozenges make them popular choices among users, while ongoing product innovations, such as flavored and sugar-free options, continue to expand their appeal across diverse consumer segments.
    This report is a detailed and comprehensive analysis for global Nicotine Gums and Lozenges market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nicotine Gums and Lozenges market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Nicotine Gums and Lozenges market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Nicotine Gums and Lozenges market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Nicotine Gums and Lozenges market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nicotine Gums and Lozenges
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nicotine Gums and Lozenges market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Perrigo Company, Pfizer, Fertin Pharma, Johnson & Johnson, Cipla, Alkalon, GSK, Reynolds American, Dr. Reddy's Laboratories, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nicotine Gums and Lozenges market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    2 mg/piece
    4 mg/piece
    Other
    Market segment by Application
    Withdrawal Clinics
    Medical Practice
    Individual Smokers
    Others
    Major players covered
    Novartis
    Perrigo Company
    Pfizer
    Fertin Pharma
    Johnson & Johnson
    Cipla
    Alkalon
    GSK
    Reynolds American
    Dr. Reddy's Laboratories
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nicotine Gums and Lozenges product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nicotine Gums and Lozenges, with price, sales quantity, revenue, and global market share of Nicotine Gums and Lozenges from 2020 to 2025.
    Chapter 3, the Nicotine Gums and Lozenges competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nicotine Gums and Lozenges breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Nicotine Gums and Lozenges market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotine Gums and Lozenges.
    Chapter 14 and 15, to describe Nicotine Gums and Lozenges sales channel, distributors, customers, research findings and conclusion.

    Buy now